Daiken Biomedical Co., Ltd.

NT$14.45As of Sun 8 Nov 2026, 12:00 UTC
TWSE:7780Consumer Staples
Country Taiwan
PE (Fwd) •••
TSR 2Y CAGR 2.68%
Div yield 4.83%
ROE 14.21%
Packaged Foods
Beta (5Y) 0.45
PE TTM 26.24
TSR TTM (9.82%)
Mkt cap NT$11.64B
ROIC 13.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$19
29.62%
(28.79%)
Hold 3|10|2|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.20
0.20
0.19
0.21
29.94%
19.47%
7.27%
5.61%
RevenueNT$B
1.146
1.113
1.175
1.224
3.33%
0.33%
4.33%
5.48%
Peers (US$351.6M)
Cap (US$)
PE
313.4M
20.81x
236.3M
14.95x
349.8M
—
Capital
TTM
5Y
10Y
Leveragex
1.238
0.377
0.309
EBIT/Intx
1.904
0.192
0.166
Own earn%
75.74
(75.41)
(67.38)
Sh yield%
24.92
30.73
29.08
Owners
Insiders/Inst%
14.95
34.42
Short interest%
2.92
SBC / revenue%
4.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
18–23
$1 testx
0.2
Incr. ROIC%
4